Evidence map›Paper›PMID 32561748›Full record

ArticleScientific data2020

Dataset of segmented nuclei in hematoxylin and eosin stained histopathology images of ten cancer types.

Le Hou, Rajarsi Gupta, John S Van Arnam, Yuwei Zhang, Kaustubh Sivalenka, Dimitris Samaras, Tahsin M Kurc, Joel H Saltz

Abstract readDataset
In one paragraph

Article in Scientific data, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Le HouComputer Science Department, 203C New Computer Science Building, Stony Brook University, Stony Brook, NY, 11794, USA.ORCID http://orcid.org/0000-0001-7323-5300
Rajarsi GuptaBiomedical Informatics Department, HSC L3-045, Stony Brook Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.
John S Van ArnamBiomedical Informatics Department, HSC L3-045, Stony Brook Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.
Yuwei ZhangBiomedical Informatics Department, HSC L3-045, Stony Brook Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.
Kaustubh SivalenkaComputer Science Department, 203C New Computer Science Building, Stony Brook University, Stony Brook, NY, 11794, USA.
Dimitris SamarasComputer Science Department, 203C New Computer Science Building, Stony Brook University, Stony Brook, NY, 11794, USA.
Tahsin M KurcBiomedical Informatics Department, HSC L3-045, Stony Brook Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.
Joel H SaltzBiomedical Informatics Department, HSC L3-045, Stony Brook Medicine, Stony Brook University, Stony Brook, NY, 11794, USA. joel.saltz@stonybrookmedicine.edu.

Funding

TCIA Sustainment and Scalability - Platforms for Quantitative Imaging Informatics in Precision MedicineU24CA215109 · NCI · UNIV OF ARKANSAS FOR MED SCIS · PI BANERJEE, IMON, PRIOR, FRED WILLIAM · 2017 to 2021
$8.5M
Image Mining for Comparative Analysis of Expression Patterns in Tissue MicroarrayR01LM009239 · NLM · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI FORAN, DAVID J, SALTZ, JOEL H. · 2007 to 2016
$4.5M
Tools to Analyze Morphology and Spatially Mapped Molecular DataU24CA180924 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI SALTZ, JOEL H. · 2014 to 2019
$3.6M
Informatics for Integrative Brain Tumor Whole Slide AnalysisR01LM011119 · NLM · STATE UNIVERSITY NEW YORK STONY BROOK · PI FORAN, DAVID J, SALTZ, JOEL H. · 2011 to 2014
$1.8M
Methods and Tools for Integrating Pathomics Data into Cancer RegistriesUG3CA225021 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI DURBIN, ERIC B., FORAN, DAVID J · 2018 to 2019
$815k
NCI NIH HHS U24 CA180924NCI NIH HHS U24 CA215109NCI NIH HHS UG3 CA225021NLM NIH HHS R01 LM009239NLM NIH HHS R01 LM011119
6 · The paper itself

Abstract

The distribution and appearance of nuclei are essential markers for the diagnosis and study of cancer. Despite the importance of nuclear morphology, there is a lack of large scale, accurate, publicly accessible nucleus segmentation data. To address this, we developed an analysis pipeline that segments nuclei in whole slide tissue images from multiple cancer types with a quality control process. We have generated nucleus segmentation results in 5,060 Whole Slide Tissue images from 10 cancer types in The Cancer Genome Atlas. One key component of our work is that we carried out a multi-level quality control process (WSI-level and image patch-level), to evaluate the quality of our segmentation results. The image patch-level quality control used manual segmentation ground truth data from 1,356 sampled image patches. The datasets we publish in this work consist of roughly 5 billion quality controlled nuclei from more than 5,060 TCGA WSIs from 10 different TCGA cancer types and 1,356 manually segmented TCGA image patches from the same 10 cancer types plus additional 4 cancer types.

Indexed as

Histological TechniquesImage Processing, Computer-AssistedCell NucleusEosine Yellowish-(YS)HematoxylinHumansNeoplasmsEosine Yellowish-(YS)Hematoxylin

Identifiers

PMID32561748
PMCPMC7305328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.